European Sleep-Wake Disorder Market
European Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Industry Overview
European sleep-wake disorder market was valued at $6.0 billion in 2025 and is projected to reach $10.7 billion by 2035, growing at a CAGR of 6.0% from 2026 to 2035. The European market continues to expand steadily, supported by rising healthcare expenditure, improved access to specialized treatment facilities, and growing public awareness regarding sleep-related health conditions. Increased adoption of advanced diagnostic technologies and therapeutic solutions has further strengthened market development across several countries in the region. In addition, favorable reimbursement structures and ongoing clinical research activities are encouraging the introduction of innovative treatment approaches. The presence of established healthcare infrastructure and a strong focus on patient-centered care are also contributing to sustained demand. Furthermore, changing lifestyle patterns and increasing stress-related disorders have led to greater attention toward long-term sleep health management across Europe.
Market Dynamics
Growing Adoption of Digital Sleep Monitoring Solutions
The European market is witnessing increasing adoption of digital monitoring technologies designed to improve the assessment and management of sleep-related conditions. Healthcare providers are integrating wearable devices, remote monitoring platforms, and AI-supported diagnostic tools to enhance patient tracking and treatment efficiency. The growing preference for home-based care solutions has also encouraged the use of connected sleep monitoring systems across several European countries. In addition, advancements in telehealth services are enabling faster consultations and continuous patient engagement. This trend is supporting improved clinical outcomes while reducing pressure on hospital-based diagnostic facilities. Rising investment in digital healthcare infrastructure continues to strengthen the long-term market outlook.
Expansion of Personalized Treatment Approaches
A significant trend shaping the European market is the increasing focus on personalized treatment strategies tailored to individual patient needs. Healthcare organizations are emphasizing customized therapies that consider patient history, severity of symptoms, and lifestyle-related factors. Pharmaceutical companies and medical device manufacturers are also developing targeted treatment options aimed at improving patient compliance and therapeutic effectiveness. The growing integration of data analytics in healthcare systems is supporting more accurate treatment planning and long-term disease management. Furthermore, collaborative research initiatives across Europe are encouraging innovation in advanced therapeutic solutions. This evolving approach is contributing to higher patient satisfaction and broader adoption of specialized care services.
Market Segmentation
- Based on the disorder type, the market is segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm sleep-wake disorders, parasomnias, dyssomnias, and others.
- Based on the treatment type, the market is segmented into pharmacological therapy, behavioral therapy, light therapy, device-based therapy, and others.
- Based on the diagnosis & management approach, the market is segmented into polysomnography & sleep studies, actigraphy-based monitoring, clinical evaluation & screening tools, and remote/digital sleep monitoring solutions.
- Based on the application, the market is segmented into hospitals, home care settings, and others.
Insomnia Segment to Lead the Market with the Largest Share
The insomnia segment continues to record stable growth across the European market due to increasing work-related stress, irregular sleep routines, and rising awareness regarding mental wellness. Demand for non-invasive treatment approaches, including cognitive behavioral therapy and digital sleep support applications, has expanded significantly in recent years. Pharmaceutical companies are also strengthening their product pipelines with therapies aimed at improving long-term sleep quality while minimizing dependency concerns. Several healthcare providers are focusing on early diagnosis programs to improve treatment accessibility and patient outcomes. Companies such as Jazz Pharmaceuticals plc and Eisai Co Ltd remain active in advancing sleep-related therapeutic offerings. The segment is further benefiting from growing collaboration between healthcare institutions and digital health technology developers.
Device-Based Therapy: A Key Segment in Market Growth
The device-based therapy segment is gaining considerable traction owing to the growing preference for technologically advanced treatment solutions for sleep-related breathing disorders. Increasing use of connected therapeutic devices and home-based respiratory support systems has contributed to wider patient adoption across European healthcare settings. Manufacturers are introducing compact and user-friendly systems designed to improve comfort, monitoring accuracy, and treatment compliance. Continuous innovation in sensor integration and remote patient tracking has also enhanced the effectiveness of long-term disease management. Key participants, including ResMed Inc and Koninklijke Philips N.V., are investing in advanced therapy platforms and digital connectivity features. Expanding reimbursement support and increasing physician recommendation rates are further supporting segment expansion.
Regional Outlook
The European sleep-wake disorder market is further divided by countries, including the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe.
Germany Dominates the Market with a Major Share
Germany continues to maintain a leading position in the European market due to its advanced healthcare infrastructure, strong reimbursement framework, and growing focus on sleep health management. Rising demand for specialized diagnostic services and increasing adoption of technologically advanced treatment solutions are supporting market expansion across the country. Healthcare providers are emphasizing early-stage screening and long-term therapy management to address the growing burden of sleep-related disorders. Companies such as ResMed Inc and Linde plc have strengthened their presence through respiratory care and sleep therapy solutions. The market is also witnessing increased integration of digital monitoring platforms within hospital and home-care settings. Ongoing clinical research activities and favorable healthcare investments continue to support sustained growth in Germany.
Market Players Outlook
The major companies operating in the European sleep-wake disorder market include Koninklijke Philips N.V., Jazz Pharmaceuticals plc, Sanofi, H. Lundbeck A/S, and LivaNova PLC, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In May 2025, ResMed Inc announced the acquisition of VirtuOx to strengthen its virtual diagnostic capabilities for sleep and respiratory disorders. The acquisition supports the expansion of home-based sleep testing services and improves patient access to early-stage diagnosis across international markets, including Europe. The company stated that the integration of VirtuOx would enhance connected care pathways and support healthcare providers with more streamlined diagnostic workflows.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the European sleep-wake disorder market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- European Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application ($ Million)
- Sleep-Wake Disorder Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Sleep-Wake Disorder Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Sleep-Wake Disorder Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For European Sleep-Wake Disorder Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For European Sleep-Wake Disorder Market: Impact Analysis
- Market Opportunities
- Opportunities For European Sleep-Wake Disorder Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Sleep-Wake Disorder Market Revenue and Share by Manufacturers
- Sleep-Wake Disorder Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Lundbeck A/S
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Jazz Pharmaceuticals plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Koninklijke Philips N.V.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- LivaNova PLC
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Sanofi
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Lundbeck A/S
- Key Company Analysis
- European Sleep-Wake Disorder Market Sales Analysis by Disorder Type ($ Million)
- Insomnia
- Hypersomnia
- Sleep Apnea
- Circadian Rhythm Sleep-Wake Disorders
- Parasomnias
- Dyssomnias
- Others
- European Sleep-Wake Disorder Market Sales Analysis by Treatment Type ($ Million)
- Pharmacological Therapy
- Behavioral Therapy
- Light Therapy
- Device-Based Therapy
- Others
- European Sleep-Wake Disorder Market Sales Analysis by Diagnosis & Management Approach ($ Million)
- Polysomnography & Sleep Studies
- Actigraphy-Based Monitoring
- Clinical Evaluation & Screening Tools
- Remote / Digital Sleep Monitoring Solutions
- European Sleep-Wake Disorder Market Sales Analysis by Application ($ Million)
- Hospitals
- Home Care Settings
- Others
- Regional Analysis
- European Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Company Profiles
- Axsome Therapeutics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BMC Medical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BRAEBON Medical Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Compumedics Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Drive DeVilbiss International
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fisher & Paykel Healthcare Corp. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lundbeck A/S
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Harmony Biosciences Holdings Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Inspire Medical Systems Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jazz Pharmaceuticals plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- LivaNova PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Löwenstein Medical SE & Co. KG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Natus Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nihon Kohden Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ProSomnus Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ResMed Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sanofi
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SomnoMed Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Takeda Pharmaceutical Company Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vanda Pharmaceuticals Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Withings
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Axsome Therapeutics Inc.
1. European Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
2. European Insomnia Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
3. European Hypersomnia Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
4. European Sleep Apnea Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
5. European Circadian Rhythm Sleep-Wake Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
6. European Parasomnias Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
7. European Dyssomnias Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
8. European Other Sleep-Wake Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
9. European Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
10. European Sleep-Wake Disorder by Pharmacological Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
11. European Sleep-Wake Disorder by Behavioral Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
12. European Sleep-Wake Disorder by Light Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
13. European Sleep-Wake Disorder by Device-Based Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
14. European Sleep-Wake Disorder by Other Treatment Type Market Research and Analysis by Region, 2025-2035 ($ Million)
15. European Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
16. European Polysomnography & Sleep Studies Market Research and Analysis by Region, 2025-2035 ($ Million)
17. European Actigraphy-Based Monitoring Market Research and Analysis by Region, 2025-2035 ($ Million)
18. European Clinical Evaluation & Screening Tools Market Research and Analysis by Region, 2025-2035 ($ Million)
19. European Remote / Digital Sleep Monitoring Solutions Market Research and Analysis by Region, 2025-2035 ($ Million)
20. European Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
21. European Sleep-Wake Disorder for Hospitals Market Research and Analysis by Region, 2025-2035 ($ Million)
22. European Sleep-Wake Disorder for Home Care Settings Market Research and Analysis by Region, 2025-2035 ($ Million)
23. European Sleep-Wake Disorder for Other Application Market Research and Analysis by Region, 2025-2035 ($ Million)
24. European Sleep-Wake Disorder Market Research and Analysis by Geography, 2025-2035 ($ Million)
25. European Sleep-Wake Disorder Market Research and Analysis by Country, 2025-2035 ($ Million)
26. European Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
27. European Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
28. European Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
29. European Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
1. European Sleep-Wake Disorder Market Share by Disorder Type, 2025 Vs 2035 (%)
2. European Insomnia Disorder Market Share by Region, 2025 Vs 2035 (%)
3. European Hypersomnia Disorder Market Share by Region, 2025 Vs 2035 (%)
4. European Sleep Apnea Disorder Market Share by Region, 2025 Vs 2035 (%)
5. European Circadian Rhythm Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
6. European Parasomnias Disorder Market Share by Region, 2025 Vs 2035 (%)
7. European Dyssomnias Disorder Market Share by Region, 2025 Vs 2035 (%)
8. European Other Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
9. European Sleep-Wake Disorder Market Share by Treatment Type, 2025 Vs 2035 (%)
10. European Sleep-Wake Disorder by Pharmacological Therapy Market Share by Region, 2025 Vs 2035 (%)
11. European Sleep-Wake Disorder by Behavioral Therapy Market Share by Region, 2025 Vs 2035 (%)
12. European Sleep-Wake Disorder by Light Therapy Market Share by Region, 2025 Vs 2035 (%)
13. European Sleep-Wake Disorder by Device-Based Therapy Market Share by Region, 2025 Vs 2035 (%)
14. European Sleep-Wake Disorder by Other Treatment Type Market Share by Region, 2025 Vs 2035 (%)
15. European Sleep-Wake Disorder Market Share by Diagnosis & Management Approach, 2025 Vs 2035 (%)
16. European Polysomnography & Sleep Studies Market Share by Region, 2025 Vs 2035 (%)
17. European Actigraphy-Based Monitoring Market Share by Region, 2025 Vs 2035 (%)
18. European Clinical Evaluation & Screening Tools Market Share by Region, 2025 Vs 2035 (%)
19. European Remote / Digital Sleep Monitoring Solutions Market Share by Region, 2025 Vs 2035 (%)
20. European Sleep-Wake Disorder Market Share by Application, 2025 Vs 2035 (%)
21. European Sleep-Wake Disorder for Hospitals Market Share by Region, 2025 Vs 2035 (%)
22. European Sleep-Wake Disorder for Home Care Settings Market Share by Region, 2025 Vs 2035 (%)
23. European Sleep-Wake Disorder for Other Application Market Share by Region, 2025 Vs 2035 (%)
24. European Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
25. UK Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
26. France Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
27. Germany Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
28. Italy Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
29. Spain Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
30. Russia Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
31. Rest Of Europe Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
